Zamagni E, Dhakal B, Iida S, Sidiqi M, Yoon S, Callander N, Touzeau C, Li Q, Balogh A, Slaughter A, Benachour N, Lonardi C, Ghosh A, Vogel M, Lendvai N, Lengil T, Koneru M, Patel N, Costa Filho O, Mahajan V, Martínez-López J, Yong K, Weisel K, Leleu X. P36 | EFFECTIVENESS OF BRIDGING THERAPY CORRESPONDS TO IMPROVED OUTCOMES AFTER CILTACABTAGENE AUTOLEUCEL: PHASE 3 CARTITUDE-4 STUDY OF PATIENTS WITH RELAPSED, LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA. Haematologica 2026; 111(s2); https://doi.org/10.3324/haematol.2026.s2.14045.